Actively Recruiting
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-03-24
70
Participants Needed
1
Research Sites
311 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Disorders of social cognition, and empathy more specifically, are at the heart of schizophrenic pathology in that they are strongly linked to the social handicap of patients. It is therefore necessary to refine our knowledge of the cognitive and affective processes behind this empathic disorder and to identify objective and easily measurable markers (related to brain functioning collected by electroencephalography) of these processes with the subsequent aim of improving their management. It is also relevant to question the trait/status nature of these empathic disorders by studying these markers in individuals presenting more or less marked schizotypic traits and therefore more or less at risk of developing schizophrenia. Studying the possibility that empathy disorders may be part of the factors of developmental vulnerability for schizophrenia and identifying objective markers of this vulnerability could allow, in case of development of the pathology, a more rapid diagnosis and a more effective management.
CONDITIONS
Official Title
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Good command of the French language
- Right-handed
- Diagnosis of schizophrenia or schizoaffective disorder
- Clinical state stabilized according to the treating psychiatrist
You will not qualify if you...
- History of head injury with loss of consciousness lasting more than 5 minutes
- Participating in another project at the time of this study
- Addiction to toxic substances (excluding tobacco)
- Mental retardation or neurological disorder
- Significant change in treatment in the previous month (patients only)
- Currently hospitalized (patients only)
- Taking psychoactive drugs (controls only)
- Having a mental disorder (controls only)
- First-degree relative of a patient with a disorder other than schizophrenia or schizoaffective disorder (controls only)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Pasteur - Service de Psychiatrie
Nice, France, 06001
Actively Recruiting
Research Team
B
Bruno GIORDANA, PH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here